| Janine Louise Meister, | |
|
530 E 2nd St, Duluth, MN 55805-1913 | |
| (218) 786-5360 | |
| Not Available |
| Full Name | Janine Louise Meister |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 530 E 2nd St, Duluth, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003849738 | NPI | - | NPPES |
| 4600492 | Other | MEDICA | |
| 70R89ME | Other | MN | BCBS |
| 42735300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 5804 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janine Louise Meister, 530 E 2nd St, Duluth, MN 55805-1913 Ph: (218) 786-5360 | Janine Louise Meister, 530 E 2nd St, Duluth, MN 55805-1913 Ph: (218) 786-5360 |
News Archive
The importance of the research and clinical care work at Joslin Diabetes Center in Boston has been affirmed by a report from the Centers for Disease Control and Prevention predicting that one-third of all U.S. adults will have diabetes by 2050 if current trends continue.
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that it will be presenting three separate presentations at the Cambridge Healthtech Institute's 4th Annual Antibacterial Drug Development Conference, Resistance is Futile: The Challenge of Antibacterial Drug Development, April 27 - 28, in San Diego, CA.
Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection.
Dendritic cells, known to be the prime movers of the body's immune response, are still notoriously difficult to study in humans. Samples, which come primarily from bone marrow or lymphoid tissue, are simply too difficult to obtain. But new research at Rockefeller University has shown scientists a way to study "authentic" dendritic cells from mouse monocytes, which are abundant in the blood, a much more accessible source in humans.
› Verified 6 days ago
Elyse Marilee Mccoshen, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Essentia Health St Mary's Medical Center, 407 East Third Street, Duluth, MN 55805 Phone: 218-786-4000 | |
Keri Jenkins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2827 E 2nd St, Duluth, MN 55812 Phone: 224-523-9968 | |
Gerald Lieberg, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 S 20th Ave W, Suite A, Duluth, MN 55806 Phone: 218-721-4732 | |
Mr. Paul Degoursey, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 E 3rd St, Duluth, MN 55805 Phone: 218-786-4000 | |
Natalie R Carl, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Ashley Weber, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2501 Rice Lake Rd, Duluth, MN 55811 Phone: 218-625-6400 |